Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lentiviral-mediated RNA interference.

Toufik Abbas-Terki1, William Blanco-Bose, Nicole Déglon

  • 1Institute of Neurosciences, Swiss Federal Institute of Technology, EPFL, Lausanne 1015, Switzerland.

Human Gene Therapy
|January 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpreting assay sensitivity and population selection in paediatric alopecia areata trials: letter in reply.

The British journal of dermatology·2026
Same author

Selective striatal pathological changes in a novel human HTT exon 1 knock-in mouse model of Huntington's disease.

Experimental neurology·2025
Same author

Gene editing for Spinocerebellar ataxia type 3 taking advantage of the human ATXN3L paralog as replacement gene.

Gene therapy·2025
Same author

Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial.

The British journal of dermatology·2025
Same author

Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity.

Translational neurodegeneration·2025
Same author

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.

Brain : a journal of neurology·2024
Same journal

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same journal

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration.

Human gene therapy·2026
Same journal

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same journal

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
Same journal

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same journal

<i>In Vivo</i> Genome Editing Approach to Disrupt Hydroxyacid Oxidase 1 for the Treatment of Primary Hyperoxaluria Type 1.

Human gene therapy·2026
See all related articles

Lentiviral vectors can effectively deliver small interfering RNA (siRNA) for long-term gene silencing in mammalian cells. This approach offers a powerful tool for gene therapy and understanding gene function.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Virology

Background:

  • RNA interference (RNAi) is a natural process for gene silencing.
  • Small interfering RNA (siRNA) mediates RNAi by degrading specific messenger RNA (mRNA).
  • Plasmid vectors have shown potential for directing siRNA synthesis in cells.

Purpose of the Study:

  • To investigate the efficacy of lentiviral vectors for encoding siRNA.
  • To establish long-term gene silencing in mammalian cells using lentiviral vectors.
  • To assess the potential of this technology for gene therapy and functional genomics.

Main Methods:

  • Engineered lentiviral vectors to express small hairpin RNA (shRNA) targeting enhanced green fluorescent protein (EGFP) using an H1-RNA promoter.
  • Introduced the lentiviral construct into mammalian cell lines stably expressing EGFP.

Related Experiment Videos

  • Analyzed EGFP expression silencing via fluorescence microscopy, flow cytometry, and Western blotting.

    • Main Results:

    • Lentiviral vectors successfully mediated gene silencing of EGFP expression.
    • Silencing was observed in two distinct EGFP-expressing cell lines.
    • The gene silencing effect was dose-dependent, initiated within 72 hours, and lasted over 25 days.

    Conclusions:

    • Lentiviral vectors encoding siRNA provide a robust platform for sustained gene silencing.
    • This technology enables specific gene targeting, offering significant potential for gene therapy applications.
    • The system serves as a valuable tool for investigating gene function and developing novel therapeutic strategies.